Skip to content

Company information lookup

ACTINOGEN LIMITED (ACW)

Commercialisation of bioactive compounds

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACW 0.016 0% 0.018 0.040 0.000 0.000 0.000 0
(Status - RE)

ACTINOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACW
Securities
Official Listing Date 16 October, 2007
GICS Industry Group Materials
Exempt Foreign? No
Internet Address http://www.actinogen.com.au
Registered Office Address Level 2, 1 Walker Avenue, WEST PERTH, WA, AUSTRALIA, 6005
Head Office Telephone +61 8 9481 3860
Head Office Fax +61 8 9321 1204
Share Registry AUTOMIC REGISTRY SERVICES
LEVEL 1, 7 VENTNOR AVENUE, WEST PERTH, WA, AUSTRALIA, 6005
Share Registry Telephone (08) 9324 2099
Directors / Senior Management
Mr Brendan De Kauwe (Executive Chairman)
Mr Daniel Parasiliti (Non Exec. Director)
Dr Anton Uvarov (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Commercialisation of bioactive compounds

ACTINOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
13/06/2014 asterix Actinogen Isolates Demonstrate Antitumorigenic Activity 2 PDF
23/04/2014   Replacement Securities Trading Policy 10 PDF
23/04/2014   Dr Brendan de Kauwe Appointed Executive Chairman 1 PDF
16/04/2014 asterix Appendix 4C & Commentary 9 PDF
10/04/2014   Section 708A Notice 1 PDF
10/04/2014   Appendix 3B - Exercise of Unlisted Options 12 PDF
18/03/2014   Investor Presentation 17 PDF
27/02/2014 asterix Appendix 4D & Half-Year Financial Statements 24 PDF
27/02/2014 asterix Actinogen & Curtin Uni to Work on Cancer Stem Cells 2 PDF
12/02/2014 asterix TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
18 Jul 2014 0.016 -33.33% 0.016 0.016 20,000
16 Jul 2014 0.024 20% 0.024 0.024 30,000
11 Jul 2014 0.020 5.26% 0.020 0.020 25,000
07 Jul 2014 0.019 0% 0.019 0.019 123,498
04 Jul 2014 0.019 72.73% 0.019 0.019 15,000

* Volume of shares shown represents only those shares traded on ASX.

ACTINOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACW. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACW

Warrants & Structured Products

No warrants & Structured Products are available over the security ACW

ASX CFDs

No Contracts For Differences are available over the security ACW